E
Euclidean Capital LLC
Euclidean Capital LLC is an institution, managing $238.0M across 11 long positions as of Q3 2025 with 87% ETF concentration, 100% concentrated in top 10 holdings, and 77% allocation to VEU.
- Portfolio Value
- $238.0M
- Positions
- 11
- Top Holding
- VEU at 77.31%
- Last Reported
- Q3 2025
Top Holdings
Largest long holdings in Euclidean Capital LLC's portfolio (100% of total portfolio)
GthenH
| Holding | Sector | Position | Weight | Traded | Ownership |
|---|---|---|---|---|---|
ETF ETF | $184.0M | 77.31% | +$31.1M Bought | — 2.6M shares | |
ETF ETF | $19.2M | 8.08% | -$107.0M Sold | — 369.6K shares | |
Biotechnology Healthcare | $11.9M | 4.99% | — | 1.02% 989.4K shares | |
Biotechnology Healthcare | $7.7M | 3.23% | — | 2.78% 1.6M shares | |
Biotechnology Healthcare | $3.9M | 1.63% | — | 1.29% 1.3M shares | |
Biotechnology Healthcare | $3.7M | 1.55% | — | 4.96% 2.6M shares | |
ETF ETF | $2.7M | 1.15% | — | — 4.1K shares | |
Biotechnology Healthcare | $2.1M | 0.89% | — | 0.50% 82.2K shares | |
Biotechnology Healthcare | $1.6M | 0.69% | — | 0.62% 1.0M shares | |
Biotechnology Healthcare | $1.1M | 0.47% | — | 1.02% 87.7K shares |
Changes
Portfolio activity, position movements, and quarter-over-quarter changes in Euclidean Capital LLC's latest filing
GthenC
Market Value
Q/Q Change
Net Flows % of MV
Turnover Ratio
New Purchases
Added To
Sold Out Of
Reduced Holdings
Increased Positions
| Position | Shares Δ |
|---|---|
+20.32% |
Decreased Positions
| Position | Shares Δ |
|---|---|
-84.76% |
Analytics
Portfolio insights and performance metrics for Euclidean Capital LLC
GthenA